<font color="blue">Quality_3</font> <font color="blue">of_2</font> <font color="blue">individual_3</font> <font color="blue">INR_3</font> <font color="blue">control_3</font> <font color="blue">and_2</font> <font color="blue">the_3</font> <font color="blue">risk_3</font> <font color="blue">of_3</font> <font color="blue">stroke_3</font> <font color="blue">and_2</font> <font color="blue">bleeding_3</font> <font color="blue">events_2</font> in <font color="blue">atrial_1</font> <font color="blue">fibrillation_1</font> patients : a <font color="blue">nested_1</font> <font color="blue">case_1</font> <font color="blue">control_1</font> <font color="blue">analysis_1</font> of the <font color="blue">ACTIVE_1</font> <font color="blue">W_1</font> study . 
<br>
<br> INTRODUCTION <font color="blue">Time_3</font> <font color="blue">in_2</font> <font color="blue">therapeutic_3</font> <font color="blue">range_3</font> <font color="blue">(_3</font> <font color="blue">TTR_3</font> <font color="blue">)_3</font> <font color="blue">for_2</font> <font color="blue">international_2</font> <font color="blue">normalized_2</font> <font color="blue">ratio_2</font> <font color="blue">(_2</font> <font color="blue">INR_2</font> <font color="blue">)_2</font> <font color="blue">is_1</font> <font color="blue">an_1</font> <font color="blue">accepted_2</font> <font color="blue">quality_2</font> <font color="blue">measure_2</font> <font color="blue">of_1</font> <font color="blue">anticoagulation_1</font> <font color="blue">control_1</font> <font color="blue">in_1</font> <font color="blue">patient_1</font> <font color="blue">populations_1</font> <font color="blue">,_1</font> <font color="blue">but_1</font> <font color="blue">its_1</font> <font color="blue">usefulness_1</font> <font color="blue">for_1</font> <font color="blue">predicting_2</font> <font color="blue">stroke_2</font> <font color="blue">and_2</font> <font color="blue">bleeding_2</font> <font color="blue">in_1</font> <font color="blue">individuals_1</font> is not well understood . 
<br> MATERIALS AND METHODS In a <font color="blue">nested_1</font> <font color="blue">case_1</font> <font color="blue">control_1</font> <font color="blue">analysis_1</font> <font color="blue">among_1</font> <font color="blue">ACTIVE_1</font> <font color="blue">W_1</font> <font color="blue">study_1</font> <font color="blue">patients_1</font> <font color="blue">,_1</font> <font color="blue">cases_1</font> <font color="blue">with_1</font> <font color="blue">stroke_1</font> and <font color="blue">cases_1</font> <font color="blue">with_1</font> <font color="blue">bleeding_1</font> were <font color="blue">separately_1</font> <font color="blue">matched_1</font> <font color="blue">with_1</font> <font color="blue">controls_1</font> <font color="blue">._1</font> <font color="blue">Several_1</font> <font color="blue">anticoagulation_3</font> <font color="blue">quality_3</font> <font color="blue">measures_3</font> <font color="blue">were_3</font> <font color="blue">compared_3</font> <font color="blue">,_3</font> <font color="blue">overall_3</font> <font color="blue">and_2</font> <font color="blue">in_3</font> <font color="blue">a_3</font> <font color="blue">time_3</font> <font color="blue">-_3</font> <font color="blue">dependent_3</font> <font color="blue">manner_3</font> <font color="blue">._3</font> 
<br> RESULTS 32 cases with <font color="blue">ischemic_1</font> <font color="blue">stroke_1</font> and 234 cases <font color="blue">with_1</font> <font color="blue">bleeding_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">analysis_1</font> <font color="blue">were_1</font> <font color="blue">matched_1</font> in a 4:1 <font color="blue">ratio_1</font> to 122 and 865 <font color="blue">controls_1</font> <font color="blue">,_1</font> respectively . <font color="blue">Follow_1</font> <font color="blue">-_1</font> <font color="blue">up_1</font> <font color="blue">duration_1</font> was 257±154days for the <font color="blue">stroke_2</font> <font color="blue">analysis_2</font> and 222±146days for the <font color="blue">bleeding_2</font> <font color="blue">analysis_2</font> <font color="blue">._2</font> <font color="blue">Compared_1</font> <font color="blue">with_1</font> <font color="blue">their_1</font> <font color="blue">respective_1</font> <font color="blue">controls_1</font> <font color="blue">,_1</font> <font color="blue">the_1</font> <font color="blue">study_2</font> <font color="blue">mean_4</font> <font color="blue">TTR_4</font> <font color="blue">of_2</font> <font color="blue">both_2</font> <font color="blue">stroke_3</font> <font color="blue">cases_3</font> ( 53.9%±25.1 vs 63.4%±24.8 ; p=0.055 ) and <font color="blue">bleeding_3</font> <font color="blue">cases_3</font> ( 56.2%±25.4 vs 63.4%±26.8 ; p<0.001 ) <font color="blue">was_1</font> <font color="blue">lower_2</font> <font color="blue">._2</font> <font color="blue">Time_3</font> <font color="blue">below_3</font> <font color="blue">range_3</font> <font color="blue">for_3</font> <font color="blue">stroke_3</font> <font color="blue">and_3</font> <font color="blue">time_3</font> <font color="blue">above_3</font> <font color="blue">range_3</font> <font color="blue">for_3</font> <font color="blue">bleeding_3</font> were only <font color="blue">greater_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">last_1</font> <font color="blue">month_1</font> <font color="blue">leading_1</font> <font color="blue">up_1</font> <font color="blue">to_1</font> <font color="blue">the_1</font> <font color="blue">event_1</font> <font color="blue">,_1</font> <font color="blue">not_1</font> <font color="blue">over_1</font> <font color="blue">the_1</font> <font color="blue">entire_1</font> <font color="blue">study_1</font> <font color="blue">period_1</font> <font color="blue">._1</font> Rather , <font color="blue">over_1</font> <font color="blue">the_1</font> <font color="blue">entire_1</font> <font color="blue">study_1</font> <font color="blue">period_1</font> <font color="blue">bleeding_2</font> <font color="blue">cases_2</font> <font color="blue">spent_1</font> <font color="blue">more_2</font> <font color="blue">time_2</font> <font color="blue">below_1</font> <font color="blue">range_1</font> <font color="blue">than_1</font> <font color="blue">controls_1</font> ( 26.8%±25.9 vs 20.8%±24.0 ; p=0.001 ) . 
<br> CONCLUSIONS <font color="blue">TTR_2</font> <font color="blue">was_2</font> <font color="blue">lower_2</font> <font color="blue">in_1</font> <font color="blue">individual_1</font> <font color="blue">AF_1</font> patients <font color="blue">with_1</font> <font color="blue">stroke_2</font> <font color="blue">or_2</font> <font color="blue">bleeding_2</font> <font color="blue">compared_1</font> <font color="blue">with_1</font> <font color="blue">matched_1</font> <font color="blue">controls_1</font> in <font color="blue">ACTIVE_1</font> <font color="blue">W._1</font> Maintaining a <font color="blue">high_1</font> <font color="blue">TTR_1</font> <font color="blue">,_1</font> with <font color="blue">equal_1</font> <font color="blue">importance_1</font> <font color="blue">to_1</font> <font color="blue">avoid_1</font> <font color="blue">low_2</font> <font color="blue">and_2</font> <font color="blue">high_2</font> <font color="blue">INRs_2</font> <font color="blue">,_2</font> is <font color="blue">a_1</font> <font color="blue">relevant_1</font> <font color="blue">goal_1</font> <font color="blue">of_1</font> <font color="blue">individual_1</font> <font color="blue">patient_1</font> <font color="blue">treatment_1</font> <font color="blue">to_1</font> <font color="blue">prevent_2</font> <font color="blue">stroke_3</font> <font color="blue">and_3</font> <font color="blue">bleeding_3</font> <font color="blue">._3</font>